Landau lab receives award for the NIH Common Fund's Somatic Mutation across Human Tissue (SMaHT) Network with the Satija lab! 5/11/2023
Dan Landau receives an Established Investigator Award from the Melanoma Research Alliance! 5/1/2023
Adam Widman receives a Young Investigator Award from the Melanoma Research Alliance! 5/1/2023
Xiaoli Mi receives the American Society of Hematology Research Training Award for Fellows! 4/21/2023
Congratulations to Landau lab members Dr. Adam Widman and Dr. Franco Izzo, winners of the New York Genome Center's Recognition Awards 2022 12/9/2022
Adam Widman, Innovation and Discovery Award
Franco Izzo, Innovation and Discovery Award
Dr. Franco Izzo
Weill Cornell Medicine Impact Feature covering the lab's work on single-cell mutiomics and cancer evolution 11/14/2022
Dan Landau receives the Jeanne and Herbert Siegel WCM Faculty Development Award
Neville Dusaj receives the F30 NCI Award!
Franco Izzo receives the ASH Fellow to Faculty Award!
Dan Landau receives the Sontag Foundation Distinguished Scientist Award
Anna Nam receives the NIH Director's Early Independence Award and starts her own lab!
Landau lab is awarded NHGRI Center of Excellence in Genomic Science award with Satija and Smibert labs at NYGC!
Dan Landau receives the Vallee Scholar Award
Anna Nam receives the Career Award for Medical Scientists from Burroughs Wellcome Fund!
Adam Widman receives a Young Investigator Award from ASCO!
Federico Gaiti receives a K99 award from the NCI!
Landau lab receives an award from CZI together with a team led by Giannerelli lab (MSSM) to develop single-cell methods to study inflammation
Dan Landau receives the Leukemia Lymphoma Society Scholar Award
Federico Gaiti receives the Lymphoma Research Foundation award!
Dan Landau is selected as a member of the American Society of Clinical Investigation
Anna Nam receives K08 from NHLBI!
Federico Gaiti selected as Leukemia Lymphoma Society Fellow!
Anna Nam selected as Leukemia Lymphoma Society Special Fellow!
Landau lab receives an ASPIRE award from the Mark Foundation to develop liquid biopsy methods for pre-invasive lesions
Landau lab in collaboration with the Kharas lab (MSKCC) receives funding from Tri-Institutional's Stem Cell Initiative Award to develop novel single-cell methods to study hematopoietic stem cell fate decisions.
Federico Gaiti receives the American Society of Hematology Scholar award!
Danny Luan receives the 2019 ASH HONORS award
Asaf Zviran receives the 2018 NYGC Innovation Award for his liquid biopsy work
Nathan Omans Selected as a NYSTEM Stem Cell Biology Scholar
Dan Landau receives the 2017 American Society of Hematology Joanne Levy, MD, Memorial Award for Outstanding Achievement
Franco Izzo awarded the American Society of Hematology Outstanding Achievement Abstract Award for submitting the top-scoring abstract of the 2017 annual meeting
Dan Landau selected for HemOnc Today’s Next Gen Innovators
Columbia University Physical Sciences in Oncology Center pilot grant awarded in collaboration with the Rabadan lab (CU) for novel multi-omics single cell technology development
This award will fund the development of novel epigenetic single-cell and editing technology
The Landau lab receives prestigious Broad Next 10 Catalytic Steps funding
The Broad Institute will provide 500,000$ in funding over the next year to develop "Modeling Cancer Diversity and Evolution for Precision Combination Cancer Therapeutics". This ambitious project will be carried out jointly with Cory Johannessen at the Broad Institute, to identify novel ways to overcome lung cancer evolution and resistance to therapy.
The Kimmel Scholar award will fund a project titled: "Knowledge infrastructure for data-driven combination leukemia therapy engineering."
Dan Landau receives the 2016 Young Physician-Scientist Award by the American Society of Clinical Investigation
To be presented in April at the AAP-ASPA-ASCI joint annual meeting in Chicago.
This award will fund the development of dynamic therapeutic optimization based on liquid biopsy technology
This award will fund the development of new liquid biopsy technology for early cancer detection
Quantitative Clonal Dynamics Define Mechanisms of CLL Evolution in Response to Combination Chemotherapy – selected for Best of ASH
Dense temporal sampling of leukemia samples from patients treated with chemoimmunotherapy enabled the study of evolutionary kinetics directly in patients. These data describe innovative methodologies to measure clone-specific growth rates with differing therapeutic contexts. The project lays the foundations for algorithmycally-driven therapy based on real-time monitoring of clonal growth. The results were presented at the annual meeting of the American Society of Hematology (ASH) and selected for the Best of ASH presentation.